Samaritan's Alzheimer's Drug Candidate Caprospinol Shows Favorable Results in Acute Toxicity Study
29 août 2006 10h52 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 29, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's research compound Caprospinol (SP-233) demonstrated...
Samaritan Strengthens Business Development Capability
23 août 2006 11h14 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 23, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it is strengthening its business development capability with...
Samaritan Pharmaceuticals Inc. Purchases Back Canadian Rights for HIV Drug from Quest PharmaTech
08 août 2006 10h34 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 8, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has purchased back the Canadian licensing rights related to...
Samaritan Plans to Acquire Metastatin Pharmaceuticals to Buy Rights to Novel Cancer Drug
27 juil. 2006 10h06 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 27, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that Samaritan has signed a letter of intent ("LOI") whereby...
Samaritan Reports Its Alzheimer's Drug Caprospinol Cleans the Brain of Plaque in Preclinical Animal Study
11 juil. 2006 09h51 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 11, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's drug SP-233 (Caprospinol), not only stops amyloid...
Samaritan Builds Up Patent Portfolio: Samaritan Announces U.S. Patent Issued for Peripheral-Type Benzodiazepine Receptor Associated Proteins
26 juin 2006 09h37 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 26, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it is continuing to expand its broad worldwide patent portfolio in...
Samaritan Receives a Notice of Claim Allowance in its European Patent for New Type of Plaque Clearing Cardiovascular Drug SP-1000
20 juin 2006 10h52 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 20, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has received a notice of allowance of claims for European patent...